Medimetriks Pharmaceuticals, Inc. Overview
Company Headquarters: New Jersey, US
Founded: 2008
Workforce: 38
Company Working:
Medimetriks Pharmaceuticals, Inc. develops prescription skincare products for the dermatology and podiatry markets. The company licenses and commercializes therapies for the treatment of acne, rosacea, seborrheic dermatitis, dystrophic nails, and impetigo. It develops and markets new products that contribute to human progress through advances in science and health. The company has MM36 (Difamilast) in Phase 2 clinical trials for atopic dermatitis.
Strategy
The strategy of Medimetriks Pharmaceuticals, Inc. is to continue advancing in therapeutic areas of acne, rosacea, atopic dermatitis, fungal infections, dystrophic nails, and impetigo by developing new products. Its mission is to discover, develop, and deliver an innovative portfolio of new products and their commercialization. It also aims to build a pipeline of prescription drug products with strong patent protection.



